NCT06588699 - Digoxin In NASH (CODIN) | Biotech Hunter

Enrollment

144

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions

NASHNAFLDMASH - Metabolic Dysfunction-Associated SteatohepatitisMashMASH With FibrosisMASLDFatty Liver DiseaseFatty Liver Disease, Nonalcoholic

Interventions

DRUG

Digoxin

Taken orally once daily

DRUG

Placebo

Matched Placebo taken orally once daily

Trial Locations (2)

RECRUITING

Yale New Haven Health, New Haven

RECRUITING

Yale New Haven Hospital, New Haven

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER